You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism

  • Technology appraisal guidance
  • Reference number: TA287
  • Published:  26 June 2013
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination document

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination document Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination document
19 April 2013
(268.29 Kb 18 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 15 April 2013

Back to top